BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15188834)

  • 1. The value of laboratory tests and ultrasonography in evaluating ovarian response to ovulation induction treatment with low-dose recombinant follicle-stimulating hormone.
    Ozkaya O; Kaya H; Sezik M; Akyürek C; Ozbaşar D
    Int J Fertil Womens Med; 2004; 49(2):83-7. PubMed ID: 15188834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of some ovarian reserve tests in poor responders.
    Vladimirov IK; Tacheva DM; Kalinov KB; Ivanova AV; Blagoeva VD
    Arch Gynecol Obstet; 2005 Jun; 272(1):74-9. PubMed ID: 15660265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening.
    Jain T; Soules MR; Collins JA
    Fertil Steril; 2004 Jul; 82(1):180-5. PubMed ID: 15237009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
    van Santbrink EJ; Fauser BC
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated clomiphene citrate challenge testing in the prediction of outcome in IVF: a comparison with basal markers for ovarian reserve.
    Hendriks DJ; Broekmans FJ; Bancsi LF; de Jong FH; Looman CW; Te Velde ER
    Hum Reprod; 2005 Jan; 20(1):163-9. PubMed ID: 15471926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged ≥35 years: a randomized controlled trial.
    Vuong TN; Phung HT; Ho MT
    Hum Reprod; 2015 May; 30(5):1188-95. PubMed ID: 25740882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH agonist protocol.
    Hohmann FP; Macklon NS; Fauser BC
    J Clin Endocrinol Metab; 2003 Jan; 88(1):166-73. PubMed ID: 12519847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial.
    Balen A; Platteau P; Andersen AN; Devroey P; Helmgaard L; Arce JC;
    Hum Reprod; 2007 Jul; 22(7):1816-23. PubMed ID: 17449511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clomiphene citrate during ovarian stimulation on the luteal phase after GnRH agonist trigger.
    Derksen L; Tournaye H; Stoop D; Van Vaerenbergh I; Bourgain C; Polyzos NP; Haentjens P; Blockeel C
    Reprod Biomed Online; 2014 Mar; 28(3):359-68. PubMed ID: 24456700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate.
    Nyboe Andersen A; Balen A; Platteau P; Devroey P; Helmgaard L; Arce JC;
    Hum Reprod; 2008 Jun; 23(6):1424-30. PubMed ID: 18372254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antral follicle count and FSH concentration after clomiphene citrate challenge test in the prediction of ovarian response during IVF treatment.
    Ng EH; Chan CC; Tang OS; Ho PC
    Hum Reprod; 2005 Jun; 20(6):1647-54. PubMed ID: 15734749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization.
    Kwee J; Schats R; McDonnell J; Schoemaker J; Lambalk CB
    Fertil Steril; 2006 Jun; 85(6):1714-22. PubMed ID: 16650416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian volume and antral follicle count for the prediction of low and hyper responders with in vitro fertilization.
    Kwee J; Elting ME; Schats R; McDonnell J; Lambalk CB
    Reprod Biol Endocrinol; 2007 Mar; 5():9. PubMed ID: 17362511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining cycle day 7 follicle count with the basal antral follicle count improves the prediction of ovarian response.
    Durmusoglu F; Elter K; Yoruk P; Erenus M
    Fertil Steril; 2004 Apr; 81(4):1073-8. PubMed ID: 15066466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary follicle-stimulating hormone (FSH) versus recombinant FSH in clomiphene citrate-resistant, normogonadotropic,chronic anovulation: a prospective randomized study.
    Yarali H; Bukulmez O; Gurgan T
    Fertil Steril; 1999 Aug; 72(2):276-81. PubMed ID: 10438995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve.
    Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C
    Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.